Table 4 |
|||||
|
PMS2 probands, type of cancer in proband and mutation information including; exon, nucleotide change, consequence of mutation and references. |
|||||
|
Family ID |
Cancer |
Exon |
Nucleotide Change |
Consequence of Mutation |
Reference LOVD database ID |
|
|
|||||
|
PMS2_3 |
CRC (55), Renal (50) |
1 8 |
c.1A>G +c.834_842del |
Alternative DNA transcript Deletion |
DB-ID: PMS2_00130 |
|
|
|||||
|
PMS2_1 PMS2_2 PMS2_5 |
CRC (41) No cancer (67) CRC (47) |
7 |
c.736_741del6ins11 |
Truncating |
DB-ID: PMS2_00187 |
|
|
|||||
|
PMS2_4 |
CRC (38) |
7 |
c.746_753del |
Truncating |
Not previously reported |
|
|
|||||
|
PMS2_6 |
CRC (60) |
9 |
c.904_1144del |
Exon deletion |
DB-ID: PMS2_00195 |
|
|
|||||
|
4 different PMS2 mutations have been detected in our patient Cohort. Not previously reported = not reported in the Leiden Open Variation Database (LOVD), the Mismatch Repair Genes Variant Database (Memorial University of Newfoundland) or the InSIGHT database as a HNPCC/Lynch syndrome mutation. DB-ID = Database identification number from LOVD. |
|||||
|
Talseth-Palmer et al. Hereditary Cancer in Clinical Practice 2010 8:5 doi:10.1186/1897-4287-8-5 |
|||||